A novel immunofluorescent assay to investigate oxidative phosphorylation deficiency in mitochondrial myopathy: understanding mechanisms and improving diagnosis.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 4606788)

Published in Sci Rep on October 15, 2015

Authors

Mariana C Rocha1,2, John P Grady2, Anne Grünewald2, Amy Vincent2, Philip F Dobson1, Robert W Taylor2, Doug M Turnbull1,2, Karolina A Rygiel1,2

Author Affiliations

1: Newcastle University Centre for Ageing and Vitality, Institute for Neuroscience, Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom.
2: Wellcome Trust Centre for Mitochondrial Research, Institute for Neuroscience, Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom.

Articles cited by this

Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci U S A (2003) 6.87

A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet (1991) 3.07

Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucleic Acids Res (2002) 2.88

Biochemical assays of respiratory chain complex activity. Methods Cell Biol (2007) 2.56

Cytochemistry and immunocytochemistry of mitochondria in tissue sections. Methods Enzymol (1996) 2.19

Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum Mol Genet (1994) 2.16

A neurological perspective on mitochondrial disease. Lancet Neurol (2010) 2.16

Mitochondrial complex I: structure, function and pathology. J Inherit Metab Dis (2006) 2.08

Automated selection of DAB-labeled tissue for immunohistochemical quantification. J Histochem Cytochem (2003) 2.07

Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagn Pathol (2012) 2.03

Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem J (1990) 1.89

The role of the LRPPRC (leucine-rich pentatricopeptide repeat cassette) gene in cytochrome oxidase assembly: mutation causes lowered levels of COX (cytochrome c oxidase) I and COX III mRNA. Biochem J (2004) 1.85

Mitochondrial DNA and disease. J Pathol (2011) 1.81

Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol (2015) 1.75

Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat (2000) 1.72

Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain (2008) 1.67

Assembly of mitochondrial complex I and defects in disease. Biochim Biophys Acta (2008) 1.67

Assembly of the oxidative phosphorylation system in humans: what we have learned by studying its defects. Biochim Biophys Acta (2008) 1.66

Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain (2008) 1.64

The diagnosis of mitochondrial muscle disease. Neuromuscul Disord (2004) 1.61

Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol (2010) 1.60

A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec. Am J Hum Genet (1993) 1.57

Nature of mitochondrial DNA deletions in substantia nigra neurons. Am J Hum Genet (2008) 1.48

HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization. Mod Pathol (2001) 1.41

Mutations of the mitochondrial ND1 gene as a cause of MELAS. J Med Genet (2004) 1.35

Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain (2006) 1.34

A partial deficiency of cytochrome c oxidase in chronic progressive external ophthalmoplegia. J Neurol Sci (1983) 1.34

Mitochondrial cytopathy. A multisystem disorder with ragged red fibres on muscle biopsy. Arch Dis Child (1981) 1.34

Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. Biochem J (1996) 1.24

The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management. J Neurol Neurosurg Psychiatry (2013) 1.23

Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: an immunohistochemical approach. Neurology (1991) 1.15

Respiratory chain complex I deficiency caused by mitochondrial DNA mutations. Eur J Hum Genet (2011) 1.14

Automated image analysis of skeletal muscle fiber cross-sectional area. J Appl Physiol (1985) (2012) 1.12

A robust automated measure of average antibody staining in immunohistochemistry images. J Histochem Cytochem (2010) 1.06

Disease progression in patients with single, large-scale mitochondrial DNA deletions. Brain (2013) 1.02

Mitochondrial DNA deletions and cytochrome c oxidase deficiency in muscle fibres. J Neurol Sci (1992) 1.01

Cytochrome oxidase immunohistochemistry: clues for genetic mechanisms. Brain (2000) 1.00

Five entry points of the mitochondrially encoded subunits in mammalian complex I assembly. Mol Cell Biol (2010) 1.00

Mitochondrial DNA deletions in inclusion body myositis. Brain (1993) 0.99

Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics. Brain (2012) 0.96

Detection of cytochrome c oxidase activity and mitochondrial proteins in single cells. J Neurosci Methods (2009) 0.91

Digital image analysis for the evaluation of the inflammatory infiltrate in psoriasis. Arch Dermatol Res (2005) 0.91

Cytochrome c oxidase-intermediate fibres: importance in understanding the pathogenesis and treatment of mitochondrial myopathy. Neuromuscul Disord (2012) 0.89

The length of cytochrome c oxidase-negative segments in muscle fibres in patients with mtDNA myopathy. Neuromuscul Disord (2002) 0.89

A comparison between manual and automated evaluations of tissue microarray patterns of protein expression. J Histochem Cytochem (2013) 0.88

Mitochondrial and inflammatory changes in sporadic inclusion body myositis. Neuropathol Appl Neurobiol (2015) 0.88

Quantitative quadruple-label immunofluorescence of mitochondrial and cytoplasmic proteins in single neurons from human midbrain tissue. J Neurosci Methods (2014) 0.87

Mitochondrial encephalomyopathy associated with a novel mutation in the mitochondrial tRNA(leu)(UUR) gene (A3243T). Biochem Biophys Res Commun (1997) 0.86

Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects. J Clin Pathol (2009) 0.84

Mitochondrial myopathies in adults and children: management and therapy development. Curr Opin Neurol (2014) 0.84

An immunocytochemical approach to detection of mitochondrial disorders. J Histochem Cytochem (2002) 0.83

Triplex real-time PCR--an improved method to detect a wide spectrum of mitochondrial DNA deletions in single cells. Sci Rep (2015) 0.83

Dissecting the mechanisms underlying the accumulation of mitochondrial DNA deletions in human skeletal muscle. Hum Mol Genet (2014) 0.79

Clinical progression of mitochondrial myopathy is associated with the random accumulation of cytochrome c oxidase negative skeletal muscle fibres. J Neurol Sci (2003) 0.79

Novel MTND1 mutations cause isolated exercise intolerance, complex I deficiency and increased assembly factor expression. Clin Sci (Lond) (2015) 0.78

Spontaneous recovery of a childhood onset mitochondrial myopathy caused by a stop mutation in the mitochondrial cytochrome c oxidase III gene. J Med Genet (2004) 0.76

Segmental cytochrome c-oxidase deficiency in CPEO: teased muscle fiber analysis. Muscle Nerve (1992) 0.76